Checkpoint Therapeutics Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Millions JOD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	2	2	5	6	2	3	Upgrade
Market Cap Growth	-26.05%	-61.02%	-16.31%	136.97%	-7.03%	17.43%	Upgrade
Last Close Price	0.96	0.88	2.17	2.55	1.04	1.07	Upgrade
PE Ratio	19.70	22.63	32.87	114.63	233.95	35.14	Upgrade
PS Ratio	14.73	15.72	25.82	61.74	49.96	22.20	Upgrade
PB Ratio	0.87	0.91	2.08	2.58	1.14	1.26	Upgrade
P/OCF Ratio	19.39	22.62	34.70	280.28	221.58	22.12	Upgrade
Asset Turnover	0.06	0.05	0.08	0.04	0.02	0.06	Upgrade
Quick Ratio	26.40	25.02	22.81	30.30	44.34	47.42	Upgrade
Current Ratio	26.40	25.02	22.82	30.32	44.34	47.42	Upgrade
Return on Equity (ROE)	4.33%	3.78%	6.44%	2.30%	0.49%	3.51%	Upgrade
Return on Assets (ROA)	4.29%	3.74%	6.37%	2.27%	0.49%	3.47%	Upgrade
Earnings Yield	4.87%	4.42%	3.04%	0.87%	0.43%	2.85%	Upgrade
Dividend Yield	4.17%	4.55%	2.76%	1.97%	3.85%	-	Upgrade
Payout Ratio	85.57%	147.57%	69.65%	162.60%	982.99%	192.17%	Upgrade
Total Shareholder Return	8.39%	4.55%	2.76%	1.97%	3.85%	-	Upgrade

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.